CDSCO Panel Tells Synokem to conduct phase 3 CT of antidiabetic FDC drug Dr. Divya Colin5 Feb 2023 12:30 PM GMTNew Delhi: Highlighting that there is no sufficient data, no unmet need & and FDC is not approved the drug internationally, the Subject Expert...
CDSCO panel tells Glenmark to submit complete clinical trial report on antidiabetic FDC Drug Dr. Nandita Mohan24 Sep 2022 12:13 PM GMTIn response to drug major Glenmark proposal to manufacture and market the antidiabetic fixed dose combination Lobeglitazone Sulphate 0.5/0.5mg plus...
Health Bulletin 24/September/2022 Dr. Nandita Mohan24 Sep 2022 11:47 AM GMTHere are the top health news for the day:Submit complete CT Report: CDSCO tells Glenmark on antidiabetic FDC drugIn response to drug major Glenmark...
CDSCO panel asks Cipla to include more Govt sites in Budesonide, Formoterol FDC study Medical Dialogues Team25 Nov 2021 12:32 PM GMTNew Delhi: Recommending to include more government sites, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Alkem gets CDSCO panel okay to manufacture, market Metformin, Sitagliptin FDC Medical Dialogues Team12 Nov 2021 12:48 PM GMTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to...
Torrent Pharma gets CDSCO panel nod to manufacture, market Pregabalin, Duloxetine FDC Medical Dialogues Team7 Nov 2021 6:15 AM GMTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to...
Glenmark gets CDSCO panel nod to market Remogliflozin, Vildagliptin, Metformin FDC drug Medical Dialogues Team12 Sep 2021 5:30 AM GMTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has given its nod to pharma major Glenmark...
NPPA panel fixes price of Dapagliflozin, Metformin FDC marketed by Aristo Pharma Medical Dialogues Team3 Sep 2021 12:54 PM GMTNew Delhi: Giving the benefits of patent expiry of popular antidiabetic drug, the National Pharmaceutical Pricing Authority (NPPA) panel has set the...
CDSCO asks drugmakers to market Tolperisone, Paracetamol FDC solely for revised indication Medical Dialogues Team2 Sep 2021 11:15 AM GMTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) has directed all State and Union Territory (UT) drug controllers to instruct all...
NPPA panel fixes retail price of Vildagliptin, Metformin FDCs marketed by Aristo Pharma Medical Dialogues Team31 Aug 2021 12:25 PM GMTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of the popular antidiabetic Fixed-Dose Combination (FDC)...
NPPA panel to examine price of antibacterial FDC Cefixime, Lactic Acid Bacillus Medical Dialogues Team30 Aug 2021 10:40 AM GMTNew Delhi: Holding that unreasonably higher price due to the addition of Lactic acid bacillus to the scheduled formulation of Cefixime 200 mg tablet...
Regularization of 31 FDCs declared rational: Drugmakers told to submit application within 6 months Medical Dialogues Team29 Aug 2021 5:45 AM GMTNew Delhi: In order to regularize Fixed Dose Combinations (FDCs) declared rational by the DTAB in respect of 294 FDCs, the Central Drugs Standard...
